Global Glucuronolactone Market by End-Use (Food & Beverage, Pharmaceutical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
"Glucuronolactone will be in high demand due to increased use by the pharmaceutical industry"
Global glucuronolactone sales reached USD 257.5 million in 2015. This market is expected to grow due to the rising pharmaceutical sector. Glucuronolactone, a chemical substance naturally found in connective tissue, such as cartilage, ligaments, and tendon, is an important part of the human body. This product can also be derived from plant gums, and is called a glucuronic Acid lactone.
The industry will expand over the forecast period due to its energizing qualities and increasing consumption in pharmaceuticals & energy drinks. Industry growth will be boosted by high use in food & drugs poisoning, liver disease, hepatitis, and adjuvant drugs to treat rheumatoidarthritis. This product is used in the precursor to vitamin C synthesis, which will drive industry growth. When glucuronolactone is introduced to the body, it quickly converts and is metabolized into substances that are safe for human health.
U.S. glucuronolactone Market Revenue, End-Use, 2013-2024 (USD Million).
A rising food and beverage sector due to increasing income levels, as well as growing urban populations is expected to drive growth. Moreover, growth is expected to be driven by increasing demand from emerging economies such as China, India and South Africa, Saudi Arabia. Egypt, Israel, Israel, and South Africa.
The industry will be driven by a growing demand for instant energy products like Monster, Red Bull, and Rockstar over the forecast period. Over the next eight year, new markets will be opened by continued research and development.
Market growth is expected to be fueled by high demand from the pharmaceutical sector.
Due to rising concerns about health conditions among consumers in India and China, the U.S. and Japan, the pharmaceutical segment will experience rapid growth at 7.0% CAGR from 2016-2024. In the United States, an increasing elderly population and a deskbound lifestyle will increase product demand over eight years.
Food & Beverage was the dominant sector accounting for 60.2%. This sector is expected to grow due to its high use as an active ingredient in energy drinks, and in health-related foods. Glucuronolactone, which converts toxins to water-soluble glucuronide, is well-known for its detoxifying abilities. The growth is expected to be accelerated by a growing urban population that is more health-conscious.
"North America's dominant position will be maintained by increasing use of glucuronolactone-based dietary supplements"
North America was responsible for 41.4% market share in 2015. It will see a significant increase in demand due to the increased use of glucuronolactone nutritional supplements in the U.S.
Companies including Red Bull, Rockstar Inc., and Monster launched various glucuronolactone-containing drinks that have been very popular in the region, which will create immense potential over the forecast period. Due to the restrictions on the use of glucose in traditional beverages, most of these drinks are sold as supplements.
Europe is set to experience substantial growth between 2016 and 2024 at 7.2% CAGR. This is due to the increased use of glucuronolactone as a prescription drug for the treatment or hepatitis, bone disease and collagen disease in Germany and the UK. The market growth will be aided by government support and increased investment in R&D.
Red Bull was the largest consumer of red bull in 2015
Aceto Corporation, Anhui Fbore Pharmaceutical and Chemical Co., Ltd., Creative Compounds, LLC, Foodchem International Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Merck Millipore Corporation, Shaoxing marina Biotechnology Co., Ltd., Shouguang Zohonghe Biochemical Co. Ltd., and Suzhou Pharmaceutical Group Co., Ltd. are key players in this market.
Rockstar, Monster Energy, Red Bull GmbH, Rockstar, Inc., Rockstar, Inc., Red Bull GmbH, Living Essential Marketing, LLC, Live, and Live are key end-users.
Hubei Yitai Pharmaceutical Co., Ltd provides glucuronolactone as a food ingredient. It is used widely in functional drinks and health foods. This product helps with fatigue recovery, immune function, anti-aging and moistening the skin.
Red Bull Energy drink is a major end-user. It offers its products in more than 169 countries and has approximately 6 billion cans annually. Red Bull's main market is the United States and Western Europe.
Up Market Research published a new report titled “Glucuronolactone Market research report which is segmented by End-Use (Food & Beverage, Pharmaceutical), By Players/Companies Shaoxing Marina Biotechnology Co, Ltd, Ltd, Anhui Fubore Pharmaceutical & Chemical Co, Suzhou Pharmaceutical Group Co, Creative Compounds, Aceto Corporation, LLC, Ltd, Shouguang Zhonghe Biochemical Co Ltd, Hubei Yitai Pharmaceutical Co, Merck Millipore Corporation, Ltd, Foodchem International Corporation”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Glucuronolactone Market Research Report |
| By End-Use | Food & Beverage, Pharmaceutical |
| By Companies | Shaoxing Marina Biotechnology Co, Ltd, Ltd, Anhui Fubore Pharmaceutical & Chemical Co, Suzhou Pharmaceutical Group Co, Creative Compounds, Aceto Corporation, LLC, Ltd, Shouguang Zhonghe Biochemical Co Ltd, Hubei Yitai Pharmaceutical Co, Merck Millipore Corporation, Ltd, Foodchem International Corporation |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 236 |
| Number of Tables & Figures | 166 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Glucuronolactone Market Report Segments:
The market is segmented by End-Use (Food & Beverage, Pharmaceutical).
Glucuronolactone Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Glucuronolactone Market
Overview of the regional outlook of the Glucuronolactone Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Glucuronolactone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Glucuronolactone Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Food & Beverage
2. Pharmaceutical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucuronolactone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Glucuronolactone Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glucuronolactone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glucuronolactone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glucuronolactone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glucuronolactone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glucuronolactone Market Size & Forecast, 2018-2028
4.5.1 Glucuronolactone Market Size and Y-o-Y Growth
4.5.2 Glucuronolactone Market Absolute $ Opportunity
Chapter 5 Global Glucuronolactone Market Analysis and Forecast by End-Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End-Use
5.1.2 Basis Point Share (BPS) Analysis by End-Use
5.1.3 Absolute $ Opportunity Assessment by End-Use
5.2 Glucuronolactone Market Size Forecast by End-Use
5.2.1 Food & Beverage
5.2.2 Pharmaceutical
5.3 Market Attractiveness Analysis by End-Use
Chapter 6 Global Glucuronolactone Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Glucuronolactone Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Glucuronolactone Analysis and Forecast
8.1 Introduction
8.2 North America Glucuronolactone Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Glucuronolactone Market Size Forecast by End-Use
8.6.1 Food & Beverage
8.6.2 Pharmaceutical
8.7 Basis Point Share (BPS) Analysis by End-Use
8.8 Absolute $ Opportunity Assessment by End-Use
8.9 Market Attractiveness Analysis by End-Use
Chapter 9 Europe Glucuronolactone Analysis and Forecast
9.1 Introduction
9.2 Europe Glucuronolactone Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Glucuronolactone Market Size Forecast by End-Use
9.6.1 Food & Beverage
9.6.2 Pharmaceutical
9.7 Basis Point Share (BPS) Analysis by End-Use
9.8 Absolute $ Opportunity Assessment by End-Use
9.9 Market Attractiveness Analysis by End-Use
Chapter 10 Asia Pacific Glucuronolactone Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Glucuronolactone Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Glucuronolactone Market Size Forecast by End-Use
10.6.1 Food & Beverage
10.6.2 Pharmaceutical
10.7 Basis Point Share (BPS) Analysis by End-Use
10.8 Absolute $ Opportunity Assessment by End-Use
10.9 Market Attractiveness Analysis by End-Use
Chapter 11 Latin America Glucuronolactone Analysis and Forecast
11.1 Introduction
11.2 Latin America Glucuronolactone Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Glucuronolactone Market Size Forecast by End-Use
11.6.1 Food & Beverage
11.6.2 Pharmaceutical
11.7 Basis Point Share (BPS) Analysis by End-Use
11.8 Absolute $ Opportunity Assessment by End-Use
11.9 Market Attractiveness Analysis by End-Use
Chapter 12 Middle East & Africa (MEA) Glucuronolactone Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Glucuronolactone Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Glucuronolactone Market Size Forecast by End-Use
12.6.1 Food & Beverage
12.6.2 Pharmaceutical
12.7 Basis Point Share (BPS) Analysis by End-Use
12.8 Absolute $ Opportunity Assessment by End-Use
12.9 Market Attractiveness Analysis by End-Use
Chapter 13 Competition Landscape
13.1 Glucuronolactone Market: Competitive Dashboard
13.2 Global Glucuronolactone Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Shaoxing Marina Biotechnology Co
13.3.2 Ltd
13.3.3 Ltd
13.3.4 Anhui Fubore Pharmaceutical & Chemical Co
13.3.5 Suzhou Pharmaceutical Group Co
13.3.6 Creative Compounds
13.3.7 Aceto Corporation
13.3.8 LLC
13.3.9 Ltd
13.3.10 Shouguang Zhonghe Biochemical Co Ltd
13.3.11 Hubei Yitai Pharmaceutical Co
13.3.12 Merck Millipore Corporation
13.3.13 Ltd
13.3.14 Foodchem International Corporation
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glucuronolactone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glucuronolactone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glucuronolactone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glucuronolactone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glucuronolactone Market Size & Forecast, 2018-2028
4.5.1 Glucuronolactone Market Size and Y-o-Y Growth
4.5.2 Glucuronolactone Market Absolute $ Opportunity
Chapter 5 Global Glucuronolactone Market Analysis and Forecast by End-Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End-Use
5.1.2 Basis Point Share (BPS) Analysis by End-Use
5.1.3 Absolute $ Opportunity Assessment by End-Use
5.2 Glucuronolactone Market Size Forecast by End-Use
5.2.1 Food & Beverage
5.2.2 Pharmaceutical
5.3 Market Attractiveness Analysis by End-Use
Chapter 6 Global Glucuronolactone Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Glucuronolactone Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Glucuronolactone Analysis and Forecast
8.1 Introduction
8.2 North America Glucuronolactone Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Glucuronolactone Market Size Forecast by End-Use
8.6.1 Food & Beverage
8.6.2 Pharmaceutical
8.7 Basis Point Share (BPS) Analysis by End-Use
8.8 Absolute $ Opportunity Assessment by End-Use
8.9 Market Attractiveness Analysis by End-Use
Chapter 9 Europe Glucuronolactone Analysis and Forecast
9.1 Introduction
9.2 Europe Glucuronolactone Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Glucuronolactone Market Size Forecast by End-Use
9.6.1 Food & Beverage
9.6.2 Pharmaceutical
9.7 Basis Point Share (BPS) Analysis by End-Use
9.8 Absolute $ Opportunity Assessment by End-Use
9.9 Market Attractiveness Analysis by End-Use
Chapter 10 Asia Pacific Glucuronolactone Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Glucuronolactone Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Glucuronolactone Market Size Forecast by End-Use
10.6.1 Food & Beverage
10.6.2 Pharmaceutical
10.7 Basis Point Share (BPS) Analysis by End-Use
10.8 Absolute $ Opportunity Assessment by End-Use
10.9 Market Attractiveness Analysis by End-Use
Chapter 11 Latin America Glucuronolactone Analysis and Forecast
11.1 Introduction
11.2 Latin America Glucuronolactone Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Glucuronolactone Market Size Forecast by End-Use
11.6.1 Food & Beverage
11.6.2 Pharmaceutical
11.7 Basis Point Share (BPS) Analysis by End-Use
11.8 Absolute $ Opportunity Assessment by End-Use
11.9 Market Attractiveness Analysis by End-Use
Chapter 12 Middle East & Africa (MEA) Glucuronolactone Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Glucuronolactone Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Glucuronolactone Market Size Forecast by End-Use
12.6.1 Food & Beverage
12.6.2 Pharmaceutical
12.7 Basis Point Share (BPS) Analysis by End-Use
12.8 Absolute $ Opportunity Assessment by End-Use
12.9 Market Attractiveness Analysis by End-Use
Chapter 13 Competition Landscape
13.1 Glucuronolactone Market: Competitive Dashboard
13.2 Global Glucuronolactone Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Shaoxing Marina Biotechnology Co
13.3.2 Ltd
13.3.3 Ltd
13.3.4 Anhui Fubore Pharmaceutical & Chemical Co
13.3.5 Suzhou Pharmaceutical Group Co
13.3.6 Creative Compounds
13.3.7 Aceto Corporation
13.3.8 LLC
13.3.9 Ltd
13.3.10 Shouguang Zhonghe Biochemical Co Ltd
13.3.11 Hubei Yitai Pharmaceutical Co
13.3.12 Merck Millipore Corporation
13.3.13 Ltd
13.3.14 Foodchem International Corporation
Segments Covered in the Report
The global Glucuronolactone market has been segmented based on
By End-Use
The global Glucuronolactone market has been segmented based on
By End-Use
- Food & Beverage
- Pharmaceutical
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Shaoxing Marina Biotechnology Co
- Ltd
- Ltd
- Anhui Fubore Pharmaceutical & Chemical Co
- Suzhou Pharmaceutical Group Co
- Creative Compounds
- Aceto Corporation
- LLC
- Ltd
- Shouguang Zhonghe Biochemical Co Ltd
- Hubei Yitai Pharmaceutical Co
- Merck Millipore Corporation
- Ltd
- Foodchem International Corporation
Our Clients
Related Reports
Some other reports from this category!
